Type Public (NASDAQ: EXAS) Number of employees ~750 (2016) Founded 1995 | Industry Molecular diagnostics Website ExactSciences.com | |
 | ||
Key people Kevin Conroy (Chairman, President &CEO)
Maneesh Arora, (COO)
Graham Lidgard, (Chief Science Officer)
Scott Coward, (General Counsel)
Jeff Elliott,(CFO) Products a non-invasive, stool DNA-based colorectal cancer screening test Stock price EXAS (NASDAQ) US$ 21.08 0.00 (0.00%)9 Mar, 4:00 PM GMT-5 - Disclaimer Headquarters Marlborough, Massachusetts, United States Profiles | ||
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer. The company was founded in 1995 in Marlborough, Massachusetts and today is headquartered in Madison, Wisconsin.
Contents
Products
In August 2014, the U.S. Food and Drug Administration (FDA) approved the company’s at-home stool DNA screening test, multitarget stool DNA screening test, for the noninvasive detection of colorectal cancers and pre-cancers.
Exact Sciences is now developing a pipeline of diagnostic tests for the early detection of lung, pancreatic and esophageal cancers.
Awards
The company was named to the InBusiness Madison “Best Companies to Work For” list in 2014 and in 2016 was the winner for large organizations in their “Best Companies to Work For” Awards.
Exact Sciences received a 2015 American Business Awards Gold Stevie for Company of the Year in the Health Products & Services category.
Exact Sciences Corporation won 2016 10th Annual Prix Galien USA Award for best medical technology product.
The company received the Business Intelligence Group’s 2016 Company of the Year BIG Award for Business in the Health Care category.